Ann Arbor MI 2型糖尿病临床试验
10项针对 2型糖尿病的研究正在 Ann Arbor及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
招募中欢迎健康志愿者
- Trinity Health Michigan Heart, Ypsilanti · 距离 7 英里
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
招募中2 期
- University of Michigan, Ann Arbor
Mechanisms of Fatigability With Diabetes
招募中
- University of Michigan, Ann Arbor
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Trinity Health Michigan Heart, Ypsilanti · 距离 7 英里
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
招募中观察性研究欢迎健康志愿者
- University of Michigan, Ann Arbor
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
招募中
- University of Michigan, Ann Arbor
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
招募中
- University of Michigan, Ann Arbor
Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
招募中
- University of Michigan, Ann Arbor
Mechanism of SGLT2 Inhibition in the Kidney
招募中4 期注明向参与者支付报酬
- University of Michigan, Ann Arbor
RESET System Pivotal Trial (Rev F)
招募中
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
其他城市的 2型糖尿病试验
- San Antonio, TX36 项研究
- Houston, TX30 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Chicago, IL19 项研究
- Miami, FL18 项研究
- Atlanta, GA18 项研究
- Columbus, OH18 项研究
- Dallas, TX18 项研究
- Las Vegas, NV17 项研究
- San Diego, CA16 项研究
- Birmingham, AL16 项研究
Ann Arbor的其他研究
- 前列腺癌27 项研究
- 乳腺癌26 项研究
- 癌症(所有类型)26 项研究
- 非小细胞肺癌25 项研究
- 结直肠癌23 项研究
- 心力衰竭22 项研究
- 肺癌22 项研究
- 急性髓系白血病17 项研究
- 心血管疾病16 项研究
- 胰腺癌14 项研究
- 黑色素瘤12 项研究
- 肾癌(肾细胞癌)12 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年9月29日。每项研究自行设定入选标准,由研究团队决定谁能参与。